one would think a million dollar a year CEO would be on this like white on rice, but Carter just doesn't care it seems.. and judging from the last quarterly report, no profit except for two years in the 80's, now 25 years later they clearly state
"We cannot assure that our product development efforts will be successfully completed or that required regulatory approvals will be obtained or that any products will be manufactured and marketed successfully, or be profitable"
Sure sounds like he just going to take the money. So "invest" if you want, but the stock price will go nowhere but down.
It took 2 1/2 years after the first CRL before HEB bothered to meet with the FDA. And even then, all that they had was a harebrained scheme to merely submitted manipulated data from studies done more than 10 years ago.
Expect the same or worse performance after the second CRL